Evolent Health (Evolent Health) Total Liabilities : $1,596 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Evolent Health Total Liabilities?

Evolent Health's Total Liabilities for the quarter that ended in Mar. 2024 was $1,596 Mil.

Evolent Health's quarterly Total Liabilities increased from Sep. 2023 ($1,573.52 Mil) to Dec. 2023 ($1,612.61 Mil) but then declined from Dec. 2023 ($1,612.61 Mil) to Mar. 2024 ($1,595.74 Mil).

Evolent Health's annual Total Liabilities increased from Dec. 2021 ($725.83 Mil) to Dec. 2022 ($957.88 Mil) and increased from Dec. 2022 ($957.88 Mil) to Dec. 2023 ($1,612.61 Mil).

Evolent Health Total Liabilities Historical Data

The historical data trend for Evolent Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Total Liabilities Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

568.97

752.10

725.83

957.88

1,612.61

Evolent Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,297.09	1,553.61	1,573.52	1,612.61	1,595.74

Evolent Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Evolent Health's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	674.242	+	(635.058	+	182.064
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	121.243	+	0)
	=	1,613

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2680.308	-	1067.701
	=	1,613

Evolent Health's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	659.022	+	(630.37	+	292.967
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	13.378	+	0)
	=	1,596

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2643.673	-	1047.936
	=	1,596

Evolent Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Evolent Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (Evolent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (NYSE:EVH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

9EH:Germany

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Executives

Seth Blackley	officer: President	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Daniel Joseph Mccarthy	officer: PRESIDENT	800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Emily Ann Rafferty	officer: Chief Operating Officer	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Toyin Ajayi	director	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Mary Bridget Duffy	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Diane Holder	director	800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Richard M Jelinek	director	40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035
Frank J Williams	director, officer: Chief Executive Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
John Paul Johnson	officer: Chief Financial Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Jonathan Weinberg	officer: General Counsel	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Steve Tutewohl	officer: Chief Operating Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Tunde Sotunde	director	800 N. GLEBE RD, SUITE 500, ARLINGTON VA 22203
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305